Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist
Contact+90 (538) 677 60 18

What Are the Current Prices of New-Generation Cancer Drugs?

ContributorsAuthor · Medical review · Editorial approval
Published
Updated
20 min read
What Are the Current Prices of New-Generation Cancer Drugs?
In this article

The drugs used in cancer treatment today span a broad range, from antibody–drug conjugates and immunotherapies to targeted precision molecules and conventional chemotherapy — and a large proportion of these drugs are now taken orally at home rather than intravenously in hospital . The table below presents the current pharmacy retail prices of oncology medicines licensed and available on the Turkish market: product name on the pack, active ingredient, formulation and dose, drug type, marketing authorization holder, and VAT-inclusive price.

Source and date of the prices: The prices in this list are based on the Turkish Medicines and Medical Devices Agency (TİTCK) reference price list dated 14 August 2026 . For most oncology drugs, the price currently in force was set by the annual update of 31 March 2026, and for some by the update of 14 August 2026. Drug prices may change during the year in line with euro exchange-rate adjustments, public-sector discounts, changes to equivalent-drug groups, and SGK reimbursement conditions.

These prices are not the amount the patient will pay out of pocket. It is very important to understand this distinction:

  • The retail priceis the VAT-inclusive list price of a prescription medicine dispensed at a pharmacy. This is the price applicable to oral medicines.
  • Medicines administered intravenously in hospital are not purchased at this price. Public hospitals and institutions contracted with SGK buy the medicine at a much lower price after the public-sector discount . The figure in the table gives an idea of that medicine’s market value; it is not reflected directly on the bill.
  • For a medicine covered by SGK reimbursement, the patient pays only the co-payment. For medicines outside reimbursement coverage, the entire amount falls to the patient. A medicine being licensed in Türkiye does not mean that SGK pays for it — these are separate processes.

Comprehensive Oncology Drug Price Reference List

The list covers, under 15 headings, a total of 178 products : in addition to intravenously administered biological agents, immunotherapies, and antibody–drug conjugates, it includes oral targeted drugs, hormonal treatments, and oral chemotherapy medicines frequently used in everyday practice.

Product Name on Pack Active Ingredient Formulation / Dose Drug Type Company Retail Price (VAT included)
1 · Antibody–Drug Conjugates and HER2-Targeted Agents
Kadcyla Trastuzumab emtansine 100 mg IV vial Original / ADC Roche 44.857,11 TL
Kadcyla Trastuzumab emtansine 160 mg IV vial Original / ADC Roche 71.682,95 TL
Enhertu Trastuzumab deruxtecan 100 mg IV vial Original / ADC Daiichi Sankyo 44.538,10 TL
Trodelvy Sacituzumab govitecan 200 mg IV vial Original / ADC Gilead 74.282,50 TL
Padcev Enfortumab vedotin 20 mg IV vial Original / ADC Astellas 27.667,82 TL
Padcev Enfortumab vedotin 30 mg IV vial Original / ADC Astellas 41.377,72 TL
Herceptin Trastuzumab 150 mg IV vial Original / reference biological product Roche 12.668,50 TL
Herzuma Trastuzumab 150 mg IV vial Biosimilar Celltrion 12.668,50 TL
Teruvia Trastuzumab 150 mg IV vial Biosimilar Yerlika Biopharma 12.506,77 TL
Trazimera Trastuzumab 150 mg IV vial Biosimilar Pfizer 12.493,70 TL
Canhera Trastuzumab 150 mg IV vial Biosimilar Abdi İbrahim 11.800,65 TL
Perjeta Pertuzumab 420 mg / 14 ml IV vial Original biological product Roche 82.921,72 TL
Phesgoro Pertuzumab + trastuzumab 1200 mg + 600 mg / 15 ml SC Original / combination biological product Roche 143.651,73 TL
Phesgoro Pertuzumab + trastuzumab 600 mg + 600 mg / 10 ml SC Original / combination biological product Roche 82.715,40 TL
2 · Immune Checkpoint Inhibitors
Keytruda Pembrolizumab 100 mg / 4 ml IV vial Original antibody MSD 88.783,52 TL *
Opdivo Nivolumab 40 mg / 4 ml IV vial Original antibody BMS 20.449,69 TL
Opdivo Nivolumab 100 mg / 10 ml IV vial Original antibody BMS 51.124,29 TL
Yervoy Ipilimumab 50 mg / 10 ml IV vial Original CTLA-4 inhibitor BMS 72.078,19 TL
Yervoy Ipilimumab 200 mg / 40 ml IV vial Original CTLA-4 inhibitor BMS 288.006,26 TL
Tecentriq Atezolizumab 840 mg / 14 ml IV vial Original antibody Roche 79.822,29 TL
Tecentriq Atezolizumab 1200 mg / 20 ml IV vial Original antibody Roche 123.966,50 TL
Imfinzi Durvalumab 500 mg / 10 ml IV vial Original antibody AstraZeneca 99.990,11 TL
Bavencio Avelumab 200 mg / 10 ml IV vial Original antibody Merck 24.428,41 TL
Jemperli Dostarlimab 500 mg / 10 ml IV vial Original antibody GSK 174.577,08 TL
3 · Anti-VEGF, Anti-EGFR, and Anti-CD20 Biological Agents
Altuzan Bevacizumab 100 mg / 4 ml IV vial Original / anti-VEGF Roche 7.206,97 TL
Altuzan Bevacizumab 400 mg / 16 ml IV vial Original / anti-VEGF Roche 26.536,43 TL
Bevax Bevacizumab 400 mg / 16 ml IV vial Biosimilar / anti-VEGF Abdi İbrahim 24.056,16 TL
Zirabev Bevacizumab 400 mg / 16 ml IV vial Biosimilar / anti-VEGF Pfizer 20.268,54 TL
Cyramza Ramucirumab 100 mg / 10 ml × 2 vial Original / anti-VEGFR2 Lilly 37.974,24 TL
Erbitux Cetuximab 100 mg / 20 ml IV vial Original / anti-EGFR Merck 10.616,54 TL
Erbitux Cetuximab 500 mg / 100 ml IV vial Original / anti-EGFR Merck 52.485,25 TL
Vectibix Panitumumab 20 mg/ml, 20 ml IV vial Original / anti-EGFR Amgen 91.337,32 TL
Mabthera Rituximab 100 mg × 2 vial Original / anti-CD20 Roche 11.712,71 TL
Mabthera Rituximab 500 mg / 50 ml IV vial Original / anti-CD20 Roche 28.961,71 TL
Mabthera SC Rituximab 1400 mg / 11,7 ml SC Original / anti-CD20 Roche 37.940,73 TL
Truxima Rituximab 100 mg / 10 ml × 2 vial Biosimilar / anti-CD20 Celltrion 11.712,71 TL
Rixathon Rituximab 100 mg / 10 ml IV vial Biosimilar / anti-CD20 Sandoz 11.712,71 TL
Rixathon Rituximab 500 mg / 10 ml IV vial Biosimilar / anti-CD20 Sandoz 28.961,71 TL
Ruxience Rituximab 500 mg / 50 ml IV vial Biosimilar / anti-CD20 Pfizer 14.820,89 TL
Gazyva Obinutuzumab 1000 mg IV vial Original / anti-CD20 Roche 76.015,93 TL
4 · IV / SC Targeted Agents for Hematological Malignancies
Darzalex Daratumumab 100 mg / 5 ml IV vial Original / anti-CD38 Johnson & Johnson 11.256,12 TL
Darzalex Daratumumab 400 mg / 20 ml IV vial Original / anti-CD38 Johnson & Johnson 44.679,66 TL
Darzalex SC Daratumumab 1800 mg SC injection Original / anti-CD38 Johnson & Johnson 134.039,08 TL
Sarclisa Isatuximab 500 mg / 25 ml IV vial Original / anti-CD38 Sanofi 62.571,61 TL
Elrexfio Elranatamab 44 mg / 1,1 ml SC Original / bispecific antibody Pfizer 84.712,45 TL
Elrexfio Elranatamab 76 mg / 1,9 ml SC Original / bispecific antibody Pfizer 146.289,88 TL
Blincyto Blinatumomab 38,5 mcg vial Original / bispecific antibody Amgen 79.357,51 TL
Besponsa Inotuzumab ozogamicin 1 mg vial Original / ADC Pfizer 604.562,94 TL
Adcetris Brentuximab vedotin 50 mg vial Original / ADC Takeda 93.066,89 TL
5 · Oral Targeted Agents — Lung Cancer
Tagrisso Osimertinib 40 mg 28 film-coated tablets Original / EGFR inhibitor AstraZeneca 239.050,10 TL
Tagrisso Osimertinib 80 mg 28 film-coated tablets Original / EGFR inhibitor AstraZeneca 239.050,10 TL
Giotrif Afatinib 20 / 30 / 40 mg 28 film-coated tablets Original / EGFR inhibitor Boehringer Ingelheim 53.749,73 TL
Iressa Gefitinib 250 mg 30 film-coated tablets Original / EGFR inhibitor AstraZeneca 38.729,91 TL
Tarceva Erlotinib 100 mg 30 film-coated tablets Original / EGFR inhibitor Roche 29.538,87 TL
Tarceva Erlotinib 150 mg 30 film-coated tablets Original / EGFR inhibitor Roche 36.797,88 TL
Xalkori Crizotinib 200 mg 60 capsules Original / ALK-ROS1 inhibitor Pfizer 119.092,59 TL
Xalkori Crizotinib 250 mg 60 capsules Original / ALK-ROS1 inhibitor Pfizer 127.169,50 TL
Alecensa Alectinib 150 mg 224 hard capsules Original / ALK inhibitor Roche 108.391,73 TL
Lorviqua Lorlatinib 25 mg 30 film-coated tablets Original / ALK inhibitor Pfizer 40.840,37 TL
Lorviqua Lorlatinib 100 mg 30 film-coated tablets Original / ALK inhibitor Pfizer 134.349,11 TL
Alunbrig Brigatinib 30 mg 28 film-coated tablets Original / ALK inhibitor Takeda 26.157,34 TL
Alunbrig Brigatinib 180 mg 28 film-coated tablets Original / ALK inhibitor Takeda 119.353,33 TL
Lumakras Sotorasib 120 mg 240 film-coated tablets Original / KRAS G12C inhibitor Amgen 257.952,14 TL
6 · Oral Targeted Agents — Breast and Gynecological Cancers
Reampla Palbociclib 75 / 100 / 125 mg 21 capsules Original / CDK4-6 inhibitor Pfizer 32.790,07 TL
Palbopol Palbociclib 125 mg 21 hard capsules Generic / CDK4-6 inhibitor Polifarma 22.688,75 TL
Paldibo Palbociclib 75 / 100 / 125 mg 21 film-coated tablets Generic / CDK4-6 inhibitor Abdi İbrahim 22.688,66 TL
Repalbo Palbociclib 75 / 100 / 125 mg 21 film-coated tablets Generic / CDK4-6 inhibitor Saba 21.404,62 TL
Valamor Ribociclib 200 mg 63 film-coated tablets CDK4-6 inhibitor Farmanova 73.519,63 TL
Yulareb Abemaciclib 50 / 100 / 150 mg 42 film-coated tablets Original / CDK4-6 inhibitor Lilly 62.529,69 TL
Lynparza Olaparib 100 mg 56 film-coated tablets Original / PARP inhibitor AstraZeneca 68.107,78 TL
Lynparza Olaparib 150 mg 56 film-coated tablets Original / PARP inhibitor AstraZeneca 68.473,97 TL
Zejula Niraparib 100 mg 56 film-coated tablets Original / PARP inhibitor GSK 119.372,92 TL
Zejula Niraparib 100 mg 56 hard capsules Original / PARP inhibitor GSK 134.964,96 TL
Pimreva Alpelisib 150 mg 56 film-coated tablets PI3K inhibitor Farmanova 141.802,41 TL
Orserdu Elacestrant 86 mg 28 film-coated tablets Original / oral SERD Menarini 105.767,41 TL
Orserdu Elacestrant 345 mg 28 film-coated tablets Original / oral SERD Menarini 317.006,36 TL
Tykerb Lapatinib 250 mg 70 film-coated tablets Original / HER2-EGFR inhibitor Novartis 30.070,35 TL
Tukysa Tucatinib 50 mg film-coated tablets Original / HER2 inhibitor Pfizer 51.872,08 TL
Tukysa Tucatinib 150 mg film-coated tablets Original / HER2 inhibitor Pfizer 148.266,67 TL
Afinitor Everolimus 5 mg 30 tablets Original / mTOR inhibitor Novartis 26.296,76 TL
Afinitor Everolimus 10 mg 30 tablets Original / mTOR inhibitor Novartis 37.790,50 TL
7 · Oral Targeted Agents — Melanoma (BRAF / MEK)
Tafinlar Dabrafenib 50 mg 120 capsules Original / BRAF inhibitor Novartis 87.728,11 TL
Tafinlar Dabrafenib 75 mg 120 capsules Original / BRAF inhibitor Novartis 131.518,29 TL
Mekinist Trametinib 0,5 mg 30 film-coated tablets Original / MEK inhibitor Novartis 30.472,94 TL
Mekinist Trametinib 2 mg 30 film-coated tablets Original / MEK inhibitor Novartis 121.448,52 TL
Braftovi Encorafenib 75 mg 42 hard capsules Original / BRAF inhibitor Pierre Fabre 47.121,42 TL
Mektovi Binimetinib 15 mg 84 film-coated tablets Original / MEK inhibitor Pierre Fabre 71.483,34 TL
Zelboraf Vemurafenib 240 mg 56 film-coated tablets Original / BRAF inhibitor Roche 36.671,05 TL
8 · Oral Multikinase Inhibitors (Kidney, Liver, Thyroid, GIST, Colorectal)
Sutent Sunitinib 25 mg 28 capsules Original / multikinase inhibitor Pfizer 31.243,44 TL
Sutent Sunitinib 37,5 mg 28 capsules Original / multikinase inhibitor Pfizer 46.791,14 TL
Tesara Sunitinib 50 mg 28 capsules Generic / multikinase inhibitor Turgut 62.338,06 TL
Nexavar Sorafenib 200 mg 112 film-coated tablets Original / multikinase inhibitor Bayer 42.033,80 TL
Votrient Pazopanib 200 mg 30 tablets Original / multikinase inhibitor Novartis 13.035,63 TL
Votrient Pazopanib 400 mg 60 tablets Original / multikinase inhibitor Novartis 51.633,42 TL
Inlyta Axitinib 5 mg 56 film-coated tablets Original / VEGFR inhibitor Pfizer 75.278,20 TL
Cabometyx Cabozantinib 20 / 40 / 60 mg film-coated tablets Original / multikinase inhibitor Gen İlaç 200.224,94 TL
Stivarga Regorafenib 40 mg 84 film-coated tablets Original / multikinase inhibitor Bayer 73.173,50 TL
Lenvapem Lenvatinib 4 mg 30 hard capsules Multikinase inhibitor Inpharmus 16.030,00 TL
9 · Oral Hematology Agents (BTK, BCL-2, CML TKI, JAK, Myeloma)
Imbruvica Ibrutinib 140 mg 120 hard capsules Original / BTK inhibitor Johnson & Johnson 226.106,41 TL
Imbruvica Ibrutinib 420 mg 30 film-coated tablets Original / BTK inhibitor Johnson & Johnson 168.753,96 TL
Calquence Acalabrutinib 100 mg 56 hard capsules Original / BTK inhibitor AstraZeneca 188.986,35 TL
Calquence Acalabrutinib 100 mg 60 film-coated tablets Original / BTK inhibitor AstraZeneca 151.893,38 TL
Venclyxto Venetoclax 100 mg 14 film-coated tablets Original / BCL-2 inhibitor AbbVie 21.343,01 TL
Venclyxto Venetoclax 100 mg 112 film-coated tablets Original / BCL-2 inhibitor AbbVie 164.504,92 TL
Glivec Imatinib 400 mg 30 film-coated tablets Original / BCR-ABL inhibitor Novartis 17.272,28 TL
Gliotin Imatinib 400 mg 30 hard capsules Generic / BCR-ABL inhibitor Abdi İbrahim 17.188,54 TL
Tasigna Nilotinib 200 mg 112 capsules Original / BCR-ABL inhibitor Novartis 60.110,36 TL
Sprycel Dasatinib 50 mg 60 film-coated tablets Original / BCR-ABL inhibitor BMS 48.518,91 TL
Dasikam Dasatinib 100 mg 30 film-coated tablets Generic / BCR-ABL inhibitor Teva 37.778,58 TL
Bosulif Bosutinib 500 mg 28 film-coated tablets Original / BCR-ABL inhibitor Pfizer 72.155,80 TL
Jakavi Ruxolitinib 5 mg 56 tablets Original / JAK inhibitor Novartis 47.521,51 TL
Jakavi Ruxolitinib 15 / 20 mg 56 tablets Original / JAK inhibitor Novartis 94.263,25 TL
Revlimid Lenalidomide 25 mg 21 capsules Original / immunomodulator BMS Celgene 67.909,99 TL
Lenatu Lenalidomide 25 mg 21 capsules Generic / immunomodulator Turkish market 60.185,59 TL
Imnovid Pomalidomide 3 mg 21 hard capsules Original / immunomodulator Er-Kim 138.322,47 TL
Pomalem Pomalidomide 4 mg 21 hard capsules Generic / immunomodulator Deva 131.748,37 TL
Thalidomide Celgene Thalidomide 50 mg 28 capsules Original / immunomodulator Er-Kim 9.163,31 TL
Rydapt Midostaurin 25 mg 112 soft capsules Original / FLT3 inhibitor Novartis 308.805,32 TL
Xospata Gilteritinib 40 mg 84 film-coated tablets Original / FLT3 inhibitor Astellas 577.948,41 TL
10 · Hormonal Treatments — Oral
Xtandi Enzalutamide 40 mg 112 soft capsules Original / androgen receptor inhibitor Astellas 73.692,23 TL
Erleada Apalutamide 60 mg 120 film-coated tablets Original / androgen receptor inhibitor Johnson & Johnson 74.087,55 TL
Nubeqa Darolutamide 300 mg 112 film-coated tablets Original / androgen receptor inhibitor Bayer 63.350,65 TL
Zytiga Abiraterone acetate 250 mg 120 tablets Original / CYP17 inhibitor Johnson & Johnson 31.299,70 TL
Zytiga Abiraterone acetate 500 mg 60 film-coated tablets Original / CYP17 inhibitor Johnson & Johnson 31.299,70 TL
Abetyl Abiraterone acetate 250 mg 120 tablets Generic / CYP17 inhibitor Abdi İbrahim 25.143,49 TL
Abyga Abiraterone acetate 500 mg 60 film-coated tablets Generic / CYP17 inhibitor Deva 23.885,00 TL
Casodex Bicalutamide 50 mg 28 film-coated tablets Original / antiandrogen Pierre Fabre 822,73 TL
Casodex Bicalutamide 150 mg 28 film-coated tablets Original / antiandrogen Pierre Fabre 2.517,13 TL
Arimidex Anastrozole 1 mg 28 tablets Original / aromatase inhibitor AstraZeneca 795,26 TL
Femara Letrozole 2,5 mg 30 film-coated tablets Original / aromatase inhibitor Novartis 848,15 TL
Letrasan Letrozole 2,5 mg 30 film-coated tablets Generic / aromatase inhibitor Deva 576,14 TL
Aromasin Exemestane 25 mg 30 coated tablets Original / aromatase inhibitor Pfizer 1.080,61 TL
Tamoxifen Tamoxifen 20 mg 30 tablets SERM Turkish market 367,73 TL
11 · Hormonal Treatments — Injectable
Faslodex Fulvestrant 250 mg / 5 ml × 2 syringe Original / SERD AstraZeneca 9.538,29 TL
Fuxran Fulvestrant 250 mg / 5 ml × 2 syringe Generic / SERD Turkish market 8.468,22 TL
Fulmesta Fulvestrant 250 mg / 5 ml × 2 syringe Generic / SERD Turkish market 7.882,32 TL
Ulvest Fulvestrant 250 mg / 5 ml syringe Generic / SERD Turkish market 6.112,46 TL
Eligard Leuprolide acetate 45 mg SC (6 months) LHRH agonist Recordati 24.708,56 TL
Eligard Leuprolide acetate 22,5 mg SC (3 months) LHRH agonist Recordati 10.732,37 TL
Lucrin Depot Leuprolide acetate 11,25 mg (3 months) LHRH agonist AbbVie 19.268,44 TL
Lucrin Depot Leuprolide acetate 3,75 mg (1 months) LHRH agonist AbbVie 7.749,19 TL
Zoladex LA Goserelin 10,8 mg depot implant LHRH agonist AstraZeneca 8.487,39 TL
Zoladex Goserelin 3,6 mg depot implant LHRH agonist AstraZeneca 3.638,96 TL
12 · Oral Cytotoxic Chemotherapy Drugs
Kapeda Capecitabine 500 mg 120 film-coated tablets Generic Koçak 3.570,56 TL
Xeltabin Capecitabine 500 mg 120 film-coated tablets Generic Teva 3.572,42 TL
Capetabin Capecitabine 500 mg 120 film-coated tablets Generic Dem 3.400,95 TL
Temodal Temozolomide 100 mg 5 capsules Original Merck 4.433,99 TL
Temodal Temozolomide 250 mg 5 capsules Original Merck 11.187,47 TL
Temomid Temozolomide 250 mg 20 capsules Generic Koçak 23.018,00 TL
Lastet Etoposide 50 mg 20 capsules Oral cytotoxic Onko Koçsel 4.990,56 TL
Alkeran Melphalan 2 mg film-coated tablets Oral alkylating agent Aspen 1.679,68 TL
Hydrea Hydroxyurea 500 mg 100 capsules Oral cytotoxic BMS 1.650,90 TL
Leukeran Chlorambucil 2 mg film-coated tablets Oral alkylating agent Aspen 1.062,58 TL
Endoxan Cyclophosphamide 50 mg 50 coated tablets Oral alkylating agent Baxter 983,02 TL
13 · Tumor-Agnostic Agents and Agents for Rare Indications
Vitrakvi Larotrectinib 100 mg 56 capsules Original / NTRK inhibitor Bayer 331.438,02 TL
Vitrakvi Larotrectinib 20 mg/ml oral solution 2 × 50 ml Original / NTRK inhibitor Bayer 118.465,90 TL
Rozlytrek Entrectinib 200 mg 90 hard capsules Original / NTRK-ROS1 inhibitor Roche 294.639,90 TL
Erivedge Vismodegib 150 mg hard capsules Original / Hedgehog inhibitor Roche 73.134,74 TL
14 · Conventional IV Chemotherapy Drugs (Reference Prices)
Alimta Pemetrexed 500 mg IV vial Original Lilly 26.762,70 TL
Pemcure Pemetrexed 500 mg IV vial Generic Turkish market 28.292,64 TL
Caelyx Liposomal doxorubicin 2 mg/ml concentrate for solution Original Baxter 20.039,16 TL
Docetu Docetaxel 80 mg IV vial Generic Turkish market 6.768,15 TL
Curatinox Oxaliplatin 100 mg IV vial Generic Turkish market 4.197,59 TL
Carbodex Carboplatin 450 mg IV vial Generic Turkish market 3.494,16 TL
Navelbine Vinorelbin 50 mg / 5 ml IV Original Turkish market 2.118,38 TL
Gemko Gemcitabine 1000 mg IV vial Generic Turkish market 1.976,91 TL
Taxatu Paclitaxel 300 mg IV vial Generic Turkish market 1.897,02 TL
Irinocam Irinotecan 100 mg IV vial Generic Turkish market 1.915,58 TL
Cisplatin-Koçak Cisplatin 50 mg IV vial Generic Koçak 1.013,69 TL
Endoxan Cyclophosphamide 1 g IV vial Original Baxter 808,12 TL
Adrimisin Doxorubicin 50 mg IV vial Generic Turkish market 609,42 TL
Etosid Etoposide 100 mg IV vial Generic Turkish market 496,29 TL
5-Frotu 5-Fluorouracil 1000 mg IV vial Generic Turkish market 268,36 TL
15 · Bone-Targeted Supportive Treatment
Xgeva Denosumab 120 mg SC vial Original / RANKL inhibitor Amgen 8.461,75 TL
Prolia Denosumab 60 mg/ml SC syringe Original / RANKL inhibitor Amgen 7.112,28 TL
Aclasta Zoledronic acid 5 mg / 100 ml IV Original / bisphosphonate Turkish market 5.678,80 TL
Zoldria Zoledronic acid 4 mg / 5 ml IV Generic / bisphosphonate Turkish market 3.324,89 TL
Zolonik Zoledronic acid 4 mg / 5 ml IV Generic / bisphosphonate Turkish market 1.476,80 TL

* Note about Keytruda: This product’s price could not be confirmed in the checked reproductions of the current TİTCK list; it appears as 88.783,52 TL in only one source. Confirmation through the pharmacy’s electronic system is recommended.

Oncology Drugs Without a Retail Price in Türkiye

Some medicines are not included in the TİTCK price list because they are not licensed in Türkiye. They are imported through the Turkish Pharmacists’ Association’s Overseas Medicine Procurement service , and their prices are generally quoted in euros rather than TL; for most of them, SGK reimbursement is subject to a separate application process.

Medicine Active ingredient Status
Lenvima Lenvatinib Imported medicine. The lenvatinib product licensed in Türkiye is Lenvapem(included in the table).
Ibrance Palbociclib Imported medicine. Palbociclib products licensed in Türkiye: Reampla, Paldibo, Palbopol, Repalbo.
Kisqali Ribociclib Imported medicine. Licensed ribociclib: Valamor.
Verzenios Abemaciclib Made inactive; it has been replaced by the same company’s Yulareb product.
Brukinsa Zanubrutinib Imported medicine; no TL price.
Nerlynx Neratinib Imported medicine; no TL price.
Iclusig Ponatinib Imported medicine. The reported price for 45 mg, 30 tablets is 4.200 euros (16.04.2026).
Lonsurf Trifluridine + tipiracil Imported medicine; no TL price.
Halaven Eribulin Imported medicine. Reported price: 149 euros (0,44 mg/ml vial).
Abraxane Nab-paclitaxel Imported medicine. Reported price: 250 euros (100 mg).
Xeloda Capecitabine The original product has no current price and is not active on the market. Its generics are listed in the table.
Krazati · Retsevmo Adagrasib · Selperkatinib Not licensed in Türkiye; also not found on the overseas medicines list.
Herceptin SC · Ontruzant · Kanjinti · Ogivri · Mvasi Trastuzumab · Bevacizumab Not included in the Turkish price list.
Opdualag · Libtayo · Polivy · Tecvayli · Talvey · Rybrevant · Columvi · Lunsumio · Empliciti · Arzerra · Firmagon Various Not included in the Turkish price list. Keytruda 400 mg and Opdivo 240 mg and 360 mg presentations are also unavailable in Türkiye.

What You Need to Know When Reading This Table

Why do different strengths of the same medicine cost the same?

Because of pricing rules in Türkiye, for some medicines all strengths have the same price. Examples include Tagrisso 40 mg and 80 mg, Giotrif 20-30-40 mg, Cabometyx 20-40-60 mg, Yulareb 50-100-150 mg, Reampla 75-100-125 mg, and Zytiga 250 mg and 500 mg. This is not a typographical error — the price per pack is fixed, and differences in strength do not affect it.

Practical implication: A dose reduction does not lower a patient’s drug cost. For example, reducing Tagrisso from 80 mg to 40 mg does not change the pack price.

Are generics always cheaper?

No. There are clear examples in this list:

  • Pemetrexed: Original Alimta 500 mg costs 26.762,70 TL , while some generics reach 28.292,64 TL and even 33.286,36 TL.
  • Trastuzumab: Original Herceptin costs 12.668,50 TL; biosimilars range from 11.800,65 to 12.668,50 TL — the difference does not exceed 7%.
  • Palbociclib: Here the difference is substantial — the original costs 32.790,07 TL, whereas generics drop to as low as 21.404,62 TL (approximately 35% cheaper).

Under the equivalent-drug system, SGK reimburses at the price of the cheapest medicine in the same equivalent group; the patient pays the difference. Therefore, choosing the most expensive generic may leave the patient paying a larger difference than with the original.

What is a biosimilar, and how does it differ from a generic?

A genericis an exact copy of a chemically synthesized small-molecule drug (for example, imatinib or abiraterone). A biosimilar is a highly similar copy of large protein molecules produced in living cells — such as trastuzumab, bevacizumab, or rituximab. Biosimilars are not “identical,” but products with “no clinically meaningful differences,” and separate comparative studies are required for licensing. They can be used in place of the reference product in terms of efficacy and safety.

Why are the prices so high?

Some figures in the table are for a single pack, and treatment generally lasts for months. For example, Xospata 40 mg, 84 tablets costs 577.948,41 TL and corresponds to approximately one month of treatment. By contrast, in the same list, a 5-Fluorouracil 1000 mg vial costs 268,36 TL. The thousandfold difference reflects not how good the drug is, but its development costs, patent status, and the size of the patient group it targets.

Price is not an indicator of efficacy. An expensive drug may not work for your type of cancer; an inexpensive drug may save lives. In breast cancer, tamoxifen costs 367,73 TL for 30 tablets and has saved thousands of lives for decades. The right medicine is not the most expensive one, but the one that fits the biology of your tumor .

My medicine is not listed. What should I do?

There are three possibilities: (1) it is not licensed in Türkiye and is being obtained as an overseas medicine; (2) it has just been licensed and is not yet included in this list; (3) its price was updated after this list was prepared. In all cases, definitive information should be based on the pharmacy’s electronic system or TİTCK’s current price list.

An honest note on sources and limitations: This list was compiled from medicine databases reflecting TİTCK’s official reference price list (ilacrehberi.com, ilacabak.com, vademecumonline.com.tr), and approximately 15 products were cross-checked between two independent sources down to the kuruş. Nevertheless, it is a secondary compilation; TİTCK’s own “Current Detailed Price List” should be used for official procedures and financial decisions. Products whose prices could not be confirmed at the source were not included; TL prices were not invented for overseas medicines, which are presented under a separate heading.

This page is for information and does not contain treatment recommendations. Your physician selects medication according to the type and stage of cancer, its molecular characteristics, previous treatments, organ function, and coexisting illnesses. A check through the pharmacy’s electronic system is recommended for the current price and reimbursement status.

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

What Are the Current Prices of New-Generation Cancer Drugs?

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy